Alcohol Consumption Clinical Trial
Official title:
Personalized Feedback to Reduce HIV+ Hazardous Drinking in Primary Care
The objective of the proposed research is test the feasibility of a brief computer-based
personalized feedback intervention to reduce heavy alcohol use among HIV+ individuals. There
is a critical need to develop accessible, empirically-supported, low-threshold interventions
for HIV+ hazardous alcohol users. The proposed research will develop and evaluate the
feasibility, acceptability, and potential efficacy of a novel evidence- and computer-based
Personalized Feedback Intervention (PFI) among HIV+ hazardous alcohol users in a high volume
Houston HIV clinic.
H1: The PFI group will show increases in self-efficacy, intention to reduce or quit drinking,
and decreases in actual drinking, relative to the control group.
H2: Reduced drinking will be associated with less risky sexual behavior, better
antiretroviral therapy (ART) medication adherence, and improved HIV quality of life.
H3: Changes in normative perceptions, alcohol use attitudes, self-efficacy for alcohol
abstinence, intentions to use, alcohol outcome expectancies, and protective behavioral
strategies will mediate intervention effects on drinking behavior. Even if the investigators
do not find significant effects on our main outcomes, these will also serve as useful
proximal dependent variables that will provide important information regarding the
feasibility of this intervention approach in this population.
H4: Intervention effects on drinking outcomes will be stronger for those who report drinking
more for social and/or coping reasons.
The objective of the proposed research is test the feasibility of a brief computer-based personalized feedback intervention to reduce heavy alcohol use among HIV+ individuals. Rates of hazardous alcohol use among HIV+ individuals are approximately two times that found in the general population. Hazardous alcohol use contributes to problems with HIV medication adherence, risky sexual behavior, and psychological problems, as well as physical complications (rapid disease progression, medication toxicities, organ failure, and poor viremic control), which may lead to increased risk of transmission and premature death. Yet, HIV+ hazardous alcohol users remain a hard-to-reach and underserved group. There is therefore a critical need to test alternative approaches to the implementation of effective interventions to reduce HIV disease transmission and progression in HIV+ hazardous alcohol users. One novel and promising intervention approach is the use of personalized feedback, which has consistently been found to be efficacious for reducing hazardous alcohol use across a number of populations. Personalized feedback highlights discrepancies between one's own drinking and typical drinking; reframes use in terms of personal, social, financial, health, and other consequences; and offers strategies for reducing use and alcohol-related negative consequences. The proposed research will develop and evaluate the feasibility, acceptability, and potential efficacy of a novel evidence- and computer-based Personalized Feedback Intervention (PFI) among HIV+ hazardous alcohol users in a high volume Houston HIV clinic. The investigators will recruit 150 HIV+ hazardous alcohol users randomly assigned to receive either PFI or attention-control feedback (e.g., diet, exercise). The investigators expect to demonstrate feasibility and acceptability of the PFI. Outcomes include drinking change processes and behavior, alcohol-related risky sexual behavior, and HIV-related outcomes. An underlying premise, which will be evaluated through the aims, is that the difficulty in reaching hazardous alcohol users who are HIV+ can be addressed with an approach that will not be burdensome to the individuals or to clinic staff. All assessments and procedures will take place in the clinic on tablets or laptop computers. Follow-up assessments will occur at 3 months post-baseline. This research builds on the collaborative work of an experienced team of investigators with complementary expertise supporting all aspects of the proposed research. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05037630 -
Feasibility Evaluation of a Self-guided Digital Tool for Problematic Alcohol Use
|
N/A | |
Completed |
NCT03037749 -
Over-arousal as a Mechanism Between Alcohol and Intimate Partner Violence
|
N/A | |
Enrolling by invitation |
NCT02927132 -
Guilt and Expressive Writing for Reducing Alcohol Use in College Students
|
N/A | |
Completed |
NCT02905123 -
Brief Internet Intervention for Hazardous Alcohol Use
|
N/A | |
Enrolling by invitation |
NCT02952495 -
Online Education to Inform the Elderly About Age-related Alcohol Risks
|
Phase 2 | |
Completed |
NCT01923246 -
Development of IVR and WEB Alcohol Interventions
|
N/A | |
Completed |
NCT01129804 -
Network Support for Alcohol Treatment 2
|
N/A | |
Completed |
NCT00374153 -
Southern Methodist Alcohol Research Trial (SMART)
|
N/A | |
Completed |
NCT01126164 -
Parent Intervention to Reduce Binge Drinking
|
N/A | |
Completed |
NCT00383838 -
Self-Selected Brief Alcohol Intervention for Adolescents
|
N/A | |
Completed |
NCT03408743 -
Engineering an Online STI Prevention Program: CSE2
|
N/A | |
Recruiting |
NCT04957628 -
AlcoTail - Implementation of Tailored Interventions
|
||
Recruiting |
NCT04164940 -
Patient Trajectories for Older Adults Admitted to Hospital for Alcohol-related Problems
|
||
Completed |
NCT00292240 -
Brief Youth Substance Use Intervention for Primary Care
|
N/A | |
Completed |
NCT04804579 -
Boston ARCH 4F Intervention to Reduce Fall Risk in People With HIV and Alcohol Use
|
N/A | |
Completed |
NCT02387489 -
A Clinical Trial of SBIRT Services in School-based Health Centers
|
N/A | |
Completed |
NCT02188446 -
Intensive Smoking and Alcohol Cessation Intervention in Bladder Cancer Surgery Patients
|
N/A | |
Completed |
NCT01688245 -
A Text Message Behavioral Intervention to Reduce Alcohol Consumption in Young Adults
|
N/A | |
Withdrawn |
NCT01739842 -
Kudzu Effects on Brain Ethanol Levels: Proton Spectroscopy Assessment
|
Phase 2/Phase 3 | |
Completed |
NCT00561587 -
Quetiapine vs. Placebo in Alcohol Relapse Prevention - a Pilot Study
|
Phase 2 |